These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7888287)

  • 41. Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.
    Silas JH; Freestone S; Lennard MS; Ramsay LE
    Br J Clin Pharmacol; 1985 Oct; 20(4):387-91. PubMed ID: 4074607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
    Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol [correction of motoprolol] in healthy Chinese subjects.
    Lee YT; Liau CS; Wong EC; Chen WJ; Chen MF; Chen CC
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):529-33. PubMed ID: 2488104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes.
    Healy ML; Gibney J; Pentecost C; Croos P; Russell-Jones DL; Sönksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2006 Jan; 91(1):320-7. PubMed ID: 16263834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
    Oosterhuis B; Jonkman JH; Kerkhof FA
    Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling.
    Børsheim E; Bahr R; Høstmark AT; Knardahl S
    Metabolism; 1998 Apr; 47(4):439-48. PubMed ID: 9550543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of carbohydrate ingestion 15 min before exercise on endurance running capacity.
    Tokmakidis SP; Karamanolis IA
    Appl Physiol Nutr Metab; 2008 Jun; 33(3):441-9. PubMed ID: 18461096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease.
    Airaksinen KE; Niemelä MJ; Huikuri HV
    Eur Heart J; 1994 Nov; 15(11):1482-5. PubMed ID: 7835362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological effects of concomitant administration of beta-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise. Effects of beta-blocker combined with beta-agonist.
    Karita M; Sato H; Koretsune Y; Imai K; Ozaki H; Yokoyama H; Hori M; Takeda H; Inoue M; Kamada T
    Eur J Clin Pharmacol; 1995; 48(6):467-71. PubMed ID: 8582465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The beta-1 adrenergic antagonist, atenolol, decreases acylation stimulating protein, exercise capacity and plasma free fatty acids in men with type 2 diabetes.
    Smith J; Ferland A; Méthot J; Brassard P; Lacroix S; Poirier P; Cianflone K
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):495-502. PubMed ID: 21247745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of beta-adrenoceptor blockade on exercise performance and metabolism.
    Lundborg P; Aström H; Bengtsson C; Fellenius E; von Schenck H; Svensson L; Smith U
    Clin Sci (Lond); 1981 Sep; 61(3):299-305. PubMed ID: 7261552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise.
    Wolfe RR; Klein S; Carraro F; Weber JM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):E382-9. PubMed ID: 2106269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.